St. Jude Children's Research Hospital
Researches and treats deadly childhood diseases – primarily cancer. Families never billed by St. Jude for treatment, travel, housing or food. Discoveries freely shared worldwide.
St. Jude Children’s Research Hospital, Inc. (St. Jude) and the American Lebanese Associated Charities, Inc. (ALSAC) are related organizations governed by a common board of directors and governors. All contributions and fundraising activities are conducted by ALSAC, which in turn provides financial support to St. Jude. The combined AFR% for both organizations is 23.9%.
- $20 could assist St. Jude in buying one toy for the hospital
play areas or recreational areas located in the lodging facilities.
- $30 could assist St. Jude in providing a St. Jude family
with meals for one day in the St. Jude cafeteria.
- $50 monthly during one year could assist St. Jude in
providing domestic airfare for one St. Jude patient.
- $57 could assist St. Jude in providing necessities for
parents when they arrive at St. Jude.
- $80 monthly during one year could assist St. Jude in
providing international airfare for one St. Jude patient.
- $90 a month for one year could assist St. Jude in providing
- $100 a month for one year could assist St. Jude in providing
a child with two days of treatment for acute lymphoblastic leukemia.
- $100 could assist St. Jude in providing a grocery gift card
for a St. Jude family in town for long-term treatment.
- $132 provides a complete blood count test.
- $150 could assist St. Jude in providing a child with one day
of Child Life specialist services.
- $210 could assist St. Jude in providing a St. Jude family
with meals for one week in the St. Jude cafeteria.
- $320 could assist St. Jude in providing a child with one
- $516 provides one hour of physical therapy
- $850 a month for one year could assist St. Jude in providing
a child with one CT scan.
Jude's groundbreaking development of combination therapy for children with
acute lymphoblastic leukemia (ALL), the most common form of childhood cancer,
revolutionized leukemia therapy worldwide and increased the survival rate from
4 percent when St. Jude opened in 1962 to 94 percent today.
- Treatments invented at St. Jude have helped push the overall childhood survival rate from 20 percent, when the hospital opened in 1962, to more than 80 percent today. St. Jude won't stop until no child dies from cancer.
- St. Jude
is the first and only National Cancer Institute-designated
Comprehensive Cancer Center devoted to children.
Jude's brain tumor science and technology are at the cutting edge worldwide,
and St. Jude has the largest research-based pediatric brain tumor research
program in the country. St. Jude is the coordinating center of the national
Pediatric Brain Tumor Consortium, which receives funding from the National
- Led by
St. Jude Director and CEO Dr. William E. Evans, St. Jude is spearheading the
emerging field of pharmacogenomics, which can predict how a patient will
respond to medications by identifying variations in specific genes that
contribute to the patient's response to certain drugs.
- St. Jude
was the first to study a computer-based three-dimensional radiation therapy
technique for pediatric brain tumor treatment to minimize damage to healthy
tissue and preserve cognitive development in children.
- St. Jude
was the first institution to produce a cure for sickle cell disease with a bone
marrow transplant and has one of the largest pediatric sickle cell disease
programs in the country.
- St. Jude
was the first center to receive government approval for a unique transplant
procedure that makes it possible for parents who are not exact matches to be
bone marrow donors for their children.
- The St.
Jude After Completion of Therapy (ACT) program is the largest long-term, follow-up
clinic for pediatric cancer patients in the United States. The Clinic's
accomplishments are now an integral part of national guidelines for screening
and managing the late effects of survivors of pediatric cancer.